a developer of novel treatments for inherited and acquired genetic disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To MGTX | 1D Price Change % | ||
---|---|---|---|---|
MGTX | 100% | -3.93% | ||
NTLA - MGTX | 49% Loosely correlated | -3.65% | ||
BEAM - MGTX | 47% Loosely correlated | -8.55% | ||
EDIT - MGTX | 46% Loosely correlated | -6.68% | ||
ANNX - MGTX | 45% Loosely correlated | -5.09% | ||
CPRX - MGTX | 45% Loosely correlated | -2.52% | ||
More |
Ticker / NAME | Correlation To MGTX | 1D Price Change % |
---|---|---|
MGTX | 100% | -3.93% |
cancer theme (87 stocks) | 51% Loosely correlated | +0.89% |
drugs theme (265 stocks) | 50% Loosely correlated | +5.37% |
biotechnology theme (248 stocks) | 50% Loosely correlated | +5.56% |
diseases theme (42 stocks) | 46% Loosely correlated | +1.03% |
novel medical theme (11 stocks) | 30% Poorly correlated | -0.49% |